Drugmakers Rail Against Compulsory Licensing

Law360, New York (December 18, 2006, 12:00 AM EST) -- Thailand faces a barrage of criticism from drug manufacturers after deciding earlier this month to issue a compulsory license for a generic version of HIV/AIDS drug Sustiva.

The Pharmaceutical Research and Manufacturers of America (PhRMA) said that the country didn’t negotiate with the patent holder, Merck & Co. Inc., before issuance.

“The recent announcement by Thailand’s Ministry of Health to issue a compulsory license without any attempt to negotiate with the patent owner is of grave concern,” said Billy Tauzin, president and CEO of PhRMA. “This...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.